Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.

Biotechnology

Novocure

Asaf Danziger

Meaghan S.

Eric Gutterson

J.m. Darrell Pruden

Chagai Komlos

Anja Götz

Stephanie Jackson

Matt Nichols

Yonathan Belicha

Nir Litver

Kuljeet Sekhon

Giovanni Battista R.

Eugenia Gelsomino

Abdelbaset Suleiman (Abed)

Vincent Keefe

Steven Robbins

Kyle Petaja

Michael Rödl

Chris Signor

Bruce Wang

Shawn Harkins

Kristina Ruppenkamp

Vallabh Godbole

Golan Bartal

Zoey Binder

Cpc Stacy Tarazewich

Ovie Onobrakpeya

Yutaka Matsumizu (Owada)

Gary F. Miller Jr.

Anna Burla

Marta Coloszynska

Dave Blazina

Katie Meyer

Michael Puri

Bill Burke

Wilco G.

Mukund Paravasthu

Ed Kenna

Tania Chander

Jonathan Tepe

Brooke Huang

Jens Hult

Peyton Reynolds

Corey Hussey

Allison Brown

Madeline Wirth

Katherine Tiku

Jeff Bamonte

Alice Reichenberger

Moshe Giladi

Frank Leonard

Ashley Cordova

Wilco Groenhuysen

Barak Ben-Arye

Uri Weinberg

The Novocure leadership team has a wealth of experience in both the business and medical industries. Board members have worked with She Built This City and Pioneering Collective, while the commercial advisor has worked with KitoTech Medical, Inc. and AVEO Oncology. The team is also highly educated, with degrees from Seton Hall University in Strategic Communications & Leadership.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Novocure

Board of Directors

CEO and Executive Team